U.K. « Science and Enterprise

Primate Genome A.I. Model IDs Human Disease Variants

By Alan, on June 2nd, 2023%

A genomic systems company created an artificial intelligence algorithm from primate genomic data that identifies possible disease-causing mutations in humans. . . . → Read More: Primate Genome A.I. Model IDs Human Disease Variants

Trial Underway Testing Psychedelic Drug for Depression

By Alan, on May 4th, 2023%

The first participant in a clinical trial received a dose of a psychedelic therapy, assessing the experimental compound in people with treatment resistant depression. . . . → Read More: Trial Underway Testing Psychedelic Drug for Depression

Venture Capital Group to Boost Climate Actions

By Alan, on April 25th, 2023%

A venture investor coalition in the U.S. and Europe announced plans to reach net zero emissions by 2030 and help start-up companies quickly achieve their zero emissions goals. . . . → Read More: Venture Capital Group to Boost Climate Actions

Biotechs Partner to Boost mRNA Manufacturing

By Alan, on April 3rd, 2023%

Two companies working in synthetic biology are advancing a new process they say increases the scale and reduces costs of messenger RNA manufacturing. . . . → Read More: Biotechs Partner to Boost mRNA Manufacturing

HPV Vaccine Generates Immune Responses in Trial

By Alan, on March 20th, 2023%

Early results from a clinical trial show a vaccine for the human papillomavirus is safe and invokes immune responses in women with low-grade cervical lesions. . . . → Read More: HPV Vaccine Generates Immune Responses in Trial

Business-Academic Team to Create RNA Delivery for Cancer

By Alan, on March 2nd, 2023%

A university lab and biotechnology company are developing new cancer treatments with therapies that stop RNA activity, delivered by advanced nanoscale particles. . . . → Read More: Business-Academic Team to Create RNA Delivery for Cancer

Bio-Electric Regeneration Company Adds $8M in Seed Funds

By Alan, on February 16th, 2023%

A start-up enterprise, spun-off from Tufts University labs, creating bio-electrical treatments for regenerating limbs and tissue, is raising $8 million in new seed funds. . . . → Read More: Bio-Electric Regeneration Company Adds $8M in Seed Funds

Nasal Spray Reduces Flu Duration in Challenge Trial

By Alan, on February 13th, 2023%

An influenza vaccine given as a nasal spray is shown in a clinical trial to reduce the amount of time participants have flu infections, when exposed to the virus. . . . → Read More: Nasal Spray Reduces Flu Duration in Challenge Trial

Trial Underway Testing Bioelectronic Incontinence Device

By Alan, on January 24th, 2023%

The first participants are enrolled in a clinical trial of an implanted bio-feedback device to help women control urinary incontinence, sudden or stress-related urges to urinate. . . . → Read More: Trial Underway Testing Bioelectronic Incontinence Device

Project to Sequence 20K Dog and Cat Genomes

By Alan, on January 9th, 2023%

Some 20,000 dogs and cats are expected to have their genomes sequenced in the next 10 years for a publicly available database to enable precision medicine for pets. . . . → Read More: Project to Sequence 20K Dog and Cat Genomes

Subscribe for email alerts

Donate to Science & Enterprise

Like us on Facebook

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Specials

Guest Posts

Please share Science & Enterprise